Minister for Health Sussan Ley
has approved Genzyme’s Myozyme
(alglucosidase alfa) for patients over
18 with late-onset Pompe disease
through the Life Saving Drugs
Programme (LSDP) from 01 Sep.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 28 Jul 15 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 Jul 15
THE Australian Consensus Framework for Ethical Collaboration in the Healthcare Sector was launched in Tokyo last week, with 50 signatories including Pharmacy Guild of Australia, SHPA, ASMI, CMA, CHF, Medicines Australia and NPS Medicinewise.